• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

NSAIDs linked with serious bleeding in afib patients

byNicholas WoolfandSai Folmsbee
November 18, 2014
in Cardiology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In patients with atrial fibrillation, the use of non-steroidal anti-inflammatory along with antithrombotic therapy (i.e., antiplatelets or anticoagulants) was associated with increased bleeding and thromboembolic events.

Evidence Rating Level: 2 (Good)

Study Rundown: Atrial fibrillation (AF) is an arrhythmia that markedly increases the risk for thromboembolic stroke. To mitigate this risk, patients are started on an oral anticoagulant (OAC), an antiplatelet, or a combined regimen. While these drugs effectively reduce the risk of stroke, they may increase the risk for serious bleeding events. Many patients with AF take non-steroidal anti-inflammatory drugs (NSAIDs) concomitantly with these antithrombotic medications, but it is unclear if NSAIDs further increase the risk of bleeding. This study, which examined data collected from Denmark’s National Patient and Prescription Registries, found that use of NSAIDs for 14 days was associated with increased risks of both serious bleeding and thromboembolic events across all anti-thrombotic treatment regimens. Among all serious bleeding events that occurred, most were either gastrointestinal or intracranial. This study was limited in that it did not account for treatment discrepancies among patients with comorbid conditions, such as hypertension. The authors also did not account for several potential confounders, including smoking status, BMI, and INR. Due to the observational nature of this study, no causal link can be established between NSAIDs and bleeding risk at this time, but clinicians should still consider such risks when prescribing NSAIDs to patients with AF.

Click to read the study today in the Annals of Internal Medicine

Relevant Reading: Use and Associated Risks of Concomitant Aspirin Therapy With Oral Anticoagulation in Patients With Atrial Fibrillation

In-Depth [retrospective cohort]: Denmark’s National Patient Registry was searched to find all patients ≥30 years of age with a first-time diagnosis of AF between 1997 and 2011. Their antithrombotic regimens were confirmed via the National Prescription Registry, and these were classified as single antiplatelet therapy (i.e., aspirin or clopidogrel), monotherapy with OACs, or dual therapy. NSAIDs were classified based on their specificity. Rofecoxib and celecoxib were designated “selective COX-2 inhibitors,” while ibuprofen, diclofenac, and naproxen were designated as “non-selective NSAIDs,” and all others were labeled “other NSAIDs.” Based on Cox regression models, the hazard ratios (HRs) for serious bleeding and thromboembolism with NSAID treatment were 2.27 (95%CI 2.15-2.40) and 1.36 (95%CI 1.27-1.45), respectively. Of the serious bleeding events, 38.7% were gastrointestinal and 18.9% were intracranial, and the HRs for gastrointestinal and intracranial bleeding were 3.54 (95%CI 3.29-3.82) and 1.22 (95%CI 1.03-1.44), respectively. The risks for bleeding and thromboembolism were increased regardless of age, sex, year of inclusion, antithrombotic treatment regimen or NSAID type.

RELATED REPORTS

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

Pulsed field ablation noninferior to cryoablation for reducing paroxysmal atrial fibrillation recurrence

More from this author: Genetic, environmental risk assessment does not increase colon cancer screening, Financial conflicts of interest bias recommendations for influenza meds, USPSTF recommends counseling for patients at high-risk for STIs, USPSTF recommends aspirin for women at risk for preeclampsia, Marked decline in cystic fibrosis-related mortality over 10 years

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: atrial fibrillationNSAID
Previous Post

Unclear if medical therapy management improves health outcomes

Next Post

Smoking linked to increased risk of chronic dysmenorrhea

RelatedReports

Atrial fibrillation-specific management increases days alive and out of hospital
Cardiology

Ablation may reduce stroke risk, death, heart failure hospitalization in patients with atrial fibrillation

July 4, 2025
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: Celebrity diagnoses spur screenings, athlete mental-health push, reality-TV heart lesson, and a sitcom PSA wave

July 2, 2025
Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors
Cardiology

Pulsed field ablation noninferior to cryoablation for reducing paroxysmal atrial fibrillation recurrence

May 30, 2025
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Left atrial appendage closure is noninferior to oral anticoagulation after ablation for atrial fibrillation

May 21, 2025
Next Post
Smoking linked to increased risk of chronic dysmenorrhea

Smoking linked to increased risk of chronic dysmenorrhea

Increased infections noted with longer duration neonatal PICC placement

Novel system rapidly detects low levels of bacteria in blood [PreClinical]

USPSTF recommends routinely screening asymptomatic women for chlamydia and gonorrhea

Men who pay for sex at higher risk of acquiring STIs

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Obicetrapib Reduced LDL Cholesterol in Patients at High Cardiovascular Risk
  • St. Louis hospital-based violence intervention program did not significantly affect reinjury outcomes
  • Glucagon-like peptide-1 receptor agonists may increase risk of reflux in patients with type 2 diabetes
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.